Search Frequenty Asked Questions

Normal Fonts Larger Fonts Printer Version Email this page Submit Feedback Questions & Answers About CMS Return to cms.hhs.gov Home Normal Fonts Larger Fonts Email this page Submit Feedback Questions & Answers About CMS Return to cms.hhs.gov Home
Return to cms.hhs.gov Home    Return to cms.hhs.gov Home

  


  Professionals   Governments   Consumers   Public Affairs

Medicare Coverage Database

Medicare Coverage home page coverage home | view page help help | view basket basket   
 
tab imageSearchtab imageIndexestab imageReportstab imageDownloadtab image 
    

Search Home > Search Results > View NCA > View Tracking Sheet

NCA Tracking Sheet for Carotid Artery Stenting in Post-Approval Studies (CAG-00259N)

Issue

Currently, Medicare only covers percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stent placement in clinical trials that receive a Category B IDE designation from the FDA. We have initiated our analysis of this device (http://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=128) and will post our final NCD in early 2005.

FDA has approved a carotid stenting system for limited indications. They have required a post approval study as a condition of approval. Due to our current non-coverage policy for carotid stents that are not part of Category B IDE trials, Medicare will be unable to pay for carotid stents in this study.

We intend to revise our current policy on carotid stents (NCD Manual 20.7) in order to extend coverage beyond Category B IDE clinical trials to include coverage of carotid artery stenting performed under the auspices of an FDA designated post approval study.

National Coverage Determination(s) 20.7
Benefit Category Inpatient Hospital Services, Physicians' Services
Requestor Name(s) Internally generated request
Formal Request Accepted and Review Initiated 9/1/2004
Expected NCA Completion Date 10/5/2004
Public Comment Period 9/1/2004 - 10/1/2004
Draft Decision Memo Due Date 9/1/2004
Draft Decision Memo Released 9/1/2004
Draft Decision Memo Public Comment Period 9/1/2004 - 10/1/2004
Decision Memo Released 10/12/2004
Lead Analyst(s) Rana Hogarth, M. H.S.
rhogarth@cms.hhs.gov
1-410-786-2112
Lead Medical Officer(s) Joe Chin, M.D.
jchin@cms.hhs.gov
1-410-786-4371
Actions Taken
September 1, 2004 In order to ensure coverage of post approval studies for this technology in a timely fashion, we are posting our draft decision memorandum  with the opening of this NCD. We are soliciting public comment on this proposed expansion of clinical trial coverage to post approval studies for carotid stents and expect to post our final decision shortly after the close of the public comment period.
October 12, 2004

Comments  from the 30-day public comment period are now available for viewing

Final Decision Memorandum  posted.



new search New Search